期刊文献+

术前化疗后乳腺癌的病理形态学改变 被引量:2

The Pathomorphological Changes of Breast Cancer after Preoperative Chemotherapy
暂未订购
导出
摘要 目的观察乳腺癌术前化疗的临床和病理改变,判断药物疗效,指导术后治疗。方法对术前化疗手术标本进行HE、免疫组织化学染色观察。结果和术前未化疗的对照组相比,乳腺癌化疗后出现瘤体变软缩小、肿瘤细胞退变坏死、间质水肿、血管周围炎症细胞浸润及异物肉芽肿形成等改变;免疫组织化学显示PCNA、CerbB2蛋白阳性表达明显降低。ER、PR表达无显著差异。结论乳腺癌术前化疗在降低肿瘤细胞增殖活力,使瘤体缩小。 Objective To observe the clinical and pathological changes of breast carcinomas after preoperative chemotherapy.Methods HE section staining and immunohistochemical labelling were used.Results The specimen after chemotherapy showed the tumor in most of the cases regressed; the tumor cells were degenerative and necrotic. The stromal edema and infiltration of inflammatory cells near the vessels in some cases, calcification and granuloma in a few cases were found. The immunohistochemical stainings showed significant lower expression in PCNA and C erbB2 protein compared with that of the control group.Conclusion The preoperative chemotherapy has the actions of promoting tumor regression and decreasing its proliferative activity to avoid spreading during an operation, in the mean time the opportunity of conservative treatment for the tumor is increased.
出处 《诊断病理学杂志》 CSCD 1998年第3期135-137,共3页 Chinese Journal of Diagnostic Pathology
关键词 乳腺癌 术前化疗 病理形态学 Breast carcinoma Preoperative chemotherapy
  • 相关文献

参考文献8

  • 1Powles TJ, Hickish A, Makris SE, et al. Bemdomized trial ofchemoendocrine therapy started befonr or after surgery for treatment of primar breast cancer J Clin Oncd, 1995.13 : 547.
  • 2Veronesi U.Booadonna G,Galimberti V.et al.Conservation surgery after primary chemotherapy in lange cancinomsa of thebreast.Ann Surg.1995.222:612
  • 3Bloom HJG.Richandaon VW.Histological grading and prognosis in breast cancer.br J Cancer.1957.11:359.
  • 4Jacquillat CL. Baillet, Weil M. et al. Results of a conservativetreatmenl cambined induction(oeo-adjuvant) and consolidation choemotherapy hornoorotherapy and ertemal and interstitial inradiahionin 98 pstients with locally advanced breast cancer(IIIA-B),Cancer,1998.61:1967.
  • 5Smith IE.Jones AL.O^1Brien MER.et al,Primary medical(becidhyvabt)chemotherapy for operable breast cancer.Eur J Cancer.1993,29A:1796.
  • 6Hortobagyi GN.Sandon F.Frei E.Managarnent of atage III prinary breaet carncer with primary chemotherapy.surgery,and radiation therapy.Cancer.1988.62-2507.
  • 7Aktepe F. Kapucuoglu N, Pak 1. The effects of chemotherapy on breast cancer tiasue in locally adranced breast cancer,Histopathol,1996,29:63.
  • 8Jain V.Landry M.Levine EA.The stability of estrogen and progesterone reocphors in patients receiving preoperative chemotherapy for locally advanced breast carcinome.Am sug,1996.62-162.

同被引文献14

  • 1E1-Didi MH, Moneer MM, Khaled HM et al .Pathdoglcal assessment of the response of locally advanced breast cancer to neoadjuvant chemotherapy and its implications for surgical management. Surg Today,2000,30:249.
  • 2Folkman J. What is the evidence that tumors are angiogenesis dependent?J Natl Cancer Inst, 1990,82:4.
  • 3Gianni L, Valagussa P,Zambetti Met al .Adjuvant and neoadjuvant treatmerit of breast cancer.Semin Oncol,2001,28:13.
  • 4Price DJ, Miralem T, Jiang S et al . Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells.Cell Growth Differ,2001,12:129.
  • 5Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist,2000,1:37.
  • 6Linderholm B, Tavelin B, Grankvist K et al . Vascular endothelial gowth factor is of high prognostic value in node-negative breast cancer.J Clin Oncol, 1998,16:3121.
  • 7Arihiro K,Kaneko M,Fujii S et al. Loss of CBO with expression of CD31and VEGF in breast carcinoma, as predictive factors of lymph node metastasis. Breast Cancer,1998,2.5,5:131.
  • 8Xie B, Tam NN, Tsao SW et al . Co-expression of vascular endothelial growth factor(VEGF) and its receptors ( flk-1 and flt-I ) in hormone-induced mammary cancer in the Noble rat. Br J Cancer, 1999,81:1335.
  • 9Fine BA, Valente PT, Feinstein GI et al . VEGF, Fit-1, and KDR/FIk-1 as prognostic indicators in endometrial carcinoma.Gynecol Oncol,.2000;76:33.
  • 10Makris A, Powles TJ, Kakolyris S et al . Ruduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma. Cancer, 1999,85 : 1996.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部